Inflammation and macular oedema after pars plana vitrectomy

V Romano, M Angi, F Scotti, R del Grosso… - Mediators of …, 2013 - Wiley Online Library
Cystoid macular oedema (CMO) is a major cause of reduced vision following intraocular
surgery. Although the aetiology of CMO is not completely clarified, intraocular inflammation …

Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion

SJ Ahn, J Ahn, SJ Woo, KH Park - BioMed Research …, 2013 - Wiley Online Library
Purpose. To compare visual and anatomic outcomes of intravitreal bevacizumab injections
administered as needed (PRN group) and initial treatment with 3 monthly injections followed …

Bevacizumab for CRVO associated CME: effect of timing and frequency of injections on final visual outcome

J Pikkel, O Chassid, Y Busool, W Srour… - Journal of …, 2013 - Wiley Online Library
Purpose. Injection of anti‐VEGF antibody into the vitreous body is a well‐established
treatment for ischemic central retinal vein occlusion (CRVO) associated macular edema …

[HTML][HTML] Long-term study of vitreomacular traction syndrome: Optical coherence tomographic patterns and surgical results

HW Huang, PT Yeh, JS Huang, CM Yang… - Taiwan Journal of …, 2013 - Elsevier
Purpose To investigate the optical coherence tomographic (OCT) patterns and long-term
surgical outcomes of patients with vitreomacular traction syndrome (VMT). Methods From …

[PDF][PDF] Treatments for Central Retinal Vein occlusion

M KaMei - assets.bmctoday.net
The conditions that are targeted by current treatments are neovascularization and macular
edema. Panretinal photocoagulation (PRP) is accepted as an established treatment for …

[PDF][PDF] Clinical Study Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch …

SJ Ahn, J Ahn, SJ Woo, KH Park - 2013 - academia.edu
Purpose. To compare visual and anatomic outcomes of intravitreal bevacizumab injections
administered as needed (PRN group) and initial treatment with 3 monthly injections followed …

[PDF][PDF] Research Article Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

J Pikkel, O Chassid, Y Busool, W Srour, A Sharabi-Nov… - 2013 - academia.edu
Purpose. Injection of anti-VEGF antibody into the vitreous body is a well-established
treatment for ischemic central retinal vein occlusion (CRVO) associated macular edema …

[引用][C] 视网膜内界膜剥离在增生性玻璃体视网膜病变的应用

鲍宁, 蒋正轩, 陶黎明, 刘东伟 - 国际眼科杂志, 2013

[引用][C] 9 Retinal Vein Occlusions

MD Paul Hahn… - Evidence-Based Eye …, 2013 - Lippincott Williams & Wilkins

[引用][C] Cystoid Macular Edema and Vitreomacular Traction

L Konstantinidis, TJ Wolfensberger - Retina, 2013 - Elsevier